Efficacy and safety of topical 0.5% 5-Fluorouracil as primary treatment of ocular surface squamous neoplasia

CONCLUSION: Topical 0.5% 5-FU may be considered a safe and effective primary therapy for OSSN, with a low rate of side effects.PMID:38631493 | DOI:10.1016/j.jcjo.2024.03.021

Source: Canadian Journal of Ophthalmology - April 17, 2024 Category: Opthalmology Authors: Juliana Mika Kato Priscilla Luppi Ballalai Patricia Picciarelli de Lima Ruth Miyuki Santo Source Type: research